This form is used specifically for oral delivery due to its improved stability compared to acetate versions
The CPT1 mechanism is inferred from preclinical work and the foundational Finan et al
INTRODUCTION Chronic hepatitis C virus (HCV) infection remains a substantial cause of chronic liver disease, affecting approximately 130 to 150 million individuals worldwide.1 An estimated 20% of patients with chronic HCV infection will develop cirrhosis.2 The prevalence of cirrhosis is increasing, primarily from continuing disease progression in an aging population that acquired HCV infection prior to widespread HCV testing and blood screening.3 Patients with cirrhosis have increased risk of severe sequelae, such as hepatic decompensation, hepatocellular carcinoma, and death.2 Conversely, clearance of HCV infection with effective treatment reduces the risk of disease progression and the need for liver transplantation, and can lead to cirrhosis regression and improved survival.4- 6 Treatment regimens containing peginterferon are problematic for patients with cirrhosis because of reduced response rates and more frequent and severe adverse events.7- 10 Furthermore, patients with cirrhosis more frequently have contraindications for peginterferon such as anemia, renal insufficiency, or thrombocytopenia
A structurally complex vitamin, B12 is formulated by a process called bacterial symbiosis
Boost Metabolism and Vitality With Powerful Ingredients Each B-12 Lipo-Plus injection has potent ingredients to support your overall wellness goals
